Pharmaceutical giant AbbVie said Tuesday that it plans to acquire Botox-maker Allergan as it builds up its portfolio in the face of looming competition for its blockbuster medication Humira.

The deal makes sense for Botox-maker Allergan, which already has a strong presence in the market for medical and facial aesthetics. Topokine's CEO, Murat Kalayoglu, said that this made Allergan ...

Jelly roll Botox is an injection for the area under your eyes, but it's not for everyone. Two doctors share more about it, ...

Botox (onabotulinumtoxinA ... considering facial injectable treatments, including some who may be interested in being treated with a faster acting shorter-duration product. Allergan will acquire ...

AbbVie (NYSE:ABBV) said Botox Cosmetic, added with its $63B acquisition of Allergan in 2020 ... first product of its kind to expand beyond the face. The approval is backed by data from Phase ...

You can get masseter Botox to make your lower face appear slimmer and less square-shaped. It can also help pain associated with TMJ, teeth grinding, or excessively clenching your jaw. The masseter ...

with Dublin-based Allergan, which has been struggling in the face of competition for some of its biggest products including the wrinkle-smoothing treatment Botox. It's the first major acquisition ...

But did you know that if you inject a neuromodulator (like Botox or Daxxify) into one area of the face, facial harmony ... and Medical Director of Allergan Medical Institute.